Pesquisa

Edição
Título
Autores
Insomnia in patients with chronic obstructive pulmonary disease: impact on prognosis and treatment approaches
Babak S., Gorbunova M., Malyavin A.
Chronic kidney disease in patients with arterial hypertension: frequency of its detection in real-life clinical practice
Bilevich O., Viktorova I., Chernykh D., Bulakhova E., Shirinskaya N.
Metabolic-associated fatty liver disease: difficulties in diagnostics and ways to overcome them
Minosyan I., Tarasova O., Kokorin V.
Modern approaches to the diagnosis and treatment of sarcopenia in patients with chronic kidney disease
Gasanov M., Batyushin M., Veber V., Chulkov V., Azovtseva O.
Sulodexide in the treatment of lower extremities chronic venous diseases: clinical effects and evidentiary basis
Golovanova O.
Clinical significance of determining nitric oxide synthesis regulators in chronic obstructive pulmonary disease in comorbidity with arterial hypertension
Kanatbekova Z., Shakhanov A., Uryasyev O., Nikiforov A.
Familial idiopathic basal ganglia calcification (Fahr disease)
Ostapchuk E., Meng A., Vorobyov A.
Diseases of the upper gastrointestinal tract in patients with diabetes mellitus (Literature review and own research)
Fedorchenko Y., Korneeva N., Martynyuk M., Tagryt I.
Role of computed tomographic dynamic myocardial perfusion in the diagnosis of functional significance of coronary artery stenosis
Dmitrieva D., Filatova D., Pavlikova E., Krasnova T., Mershina E., Lisitskaya M., Trukhanova M., Seredenina E., Vaypan D., Polyakov R., Vartanyan E., Sinitsyn V.
Phenotyping of patients with arterial hypertension based on the renal filtration function and arterial stiffness using cluster analysis
Kuchin K., Butusov M., Klemenov A.
Peculiarities of the choice of therapy for inflammatory bowel diseases associated with malignant neoplasms
Barysheva O., Golubeva A., Egorova K., Vezikova N., Varlamova D.
Ursosan in the complex treatment of patients with non-alcoholic fatty liver disease and its role in the correction of metabolic disorders (Svet study)
Cheremukhina Y., Borovkova N., Ermilova O., Tokareva A., Kuznetsov A., Vasilkova A.
Clinical and demographic characteristics, prevalence of cardiometabolic risk factors and peculiarities of the clinical course of hypertrophic cardiomyopathy in different age groups. Part one
Gudkova A., Bezhanishvili T.
Patient with non-alcoholic fatty liver disease at care encounter of a therapist: Aspects of diagnostics and treatment
Turkina S., Statsenko M., Kosivtsova M., Titarenko M., Tyshchenko I.
Life quality as a prognostic factor for treatment success in case of metabolic-associated fatty liver disease
Turkina S.
«Colossus with feet of clay»: a case report
Adasheva T., Gubernatorova E., Boltikova V., Akhmedyarova L., Bagatyrova K.
Laboratory and instrumental criteria and some mechanisms of osteopenic syndrome in case of inflammatory bowel diseases
Kozlova I., Kudishina M., Bykova A., Uris D.
Polyneuropathy in Sjogren’s syndrome – a long path from symptom to diagnosis
Ostapchuk E., Gorbachevsky A., Vorobyev A.
Case of comorbid pathology: exacerbation of gastric ulcer in a patient with type A hemophilia and chronic viral hepatitis C
Kostenko D., Rogachikov Y., Kramareva O., Luchinin M.
The COPD exacerbations equation: What do we know about variables? (Literature review)
Kostenko D.
Cardiovascular and metabolic risks in patients with obesity and non-alcoholic fatty liver disease
Kislyak O., Mikaelyan A., Starodubova A., Kosyura S.
Hyperuricemia and reduced glomerular filtration rate in the population among Nizhny Novgorod region inhabitants
Borovkova N., Kurashin V., Tokareva A., Makarova E., Nekrasov A., Savitskaya N., Mironov M.
Diagnostic value of systemic inflammation and endothelial dysfunction markers in the formation of chronic obstructive pulmonary disease clinical phenotypes
Tayutina T., Shlyk S.
Influence of hyperuricemia at the efficacy of hypolypidemic therapy in patients with chronic forms of ischemic heart disease
Sergeeva O., Salamatova V., Kotova Y., Shevtsov A., Shevtsova V.
Gliflozins as remedies for correction of neurological complications of non-alcoholic fatty liver disease. Part 1
Prikhodko V., Okovityi S.
MicroRNA-1 and microRNA-133: Small molecules of great importance in the aspect of cardiovascular diseases
Aliyeva A., Teplova N., Butenko A., Averin E., Akhmedova M., Shikhova Y., Valiev R., Sariyev M., Kotikova I., Nikitin I.
Endothelial functional activity, inflammation level in patients with arterial hypertension combined with chronic obstructive pulmonary disease during combination therapy with meldonium
Mikhin V., Khlebodarova E., Khlebodarov F., Vasilyeva D., Chernyatina M., Nikolenko T., Kostina N., Maltseva L.
Comorbidity of chronic obstructive pulmonary disease and anemia: Clinical course peculiarities, diagnosis, therapy
Budnevsky A., Gubanov D., Bavykina I., Makeeva A., Budnevskaya S., Chernik T.
A case of atherotrombotic variant of ischemic stroke in crohn’s disease patient
Tarasova L., Kucherova N.
Increasing of glomeral filtration rate in the setting of serum uric acid normalization in high cardiovascular risk patients – clinical observations
Gaydukova I., Mazurov V., Inamova O., Tsinzerling A., Bashkinov R.
Relationship between arterial pressure indexes and structura-functional condition of myocardium in patients with stage 5d chronic kidney disease
Ievlev E., Kazakova I.
Clinical efficacy of the combination of indacaterol and glycopyrronium bromide in the treatment of chronic obstructive pulmonary disease at smoking cessation stage
Kupaev V., A. Osipov D.
The importance of new therapeutic targets for neutrophil inflammation regulation in case of broncho-obstructive pulmonary diseases
Kupaev V., Shagurov A., Limareva L., Tkachenko K., Kuritsyna A.
Clinical case of orthotopic cardiac transplantation with further acute humoral rejection of the graft
Kobzeva N., Shlyk S., Amarna S., Oleynikova V.
Still’s disease in adults: methodological recommendations for general practitioners, therapists
Mazurov V., Trofimov E., Gaydukova I., Trofimova A.
Clinical and biochemical parameters in patients having coronary heart disease complicated by chronic heart failure with low and preserved ejection fraction
Skuratova M., Lebedev P., Bratchenko I., Bratchenko L., Lyamin A., Kuritsyna A., Komarova M.
Comorbidity of chronic obstructive pulmonary disease and cardiovascular pathology: Current state of the problem
Melnik M., Kanorsky S.
From empirical medicine – to analytical medicine
Volkova N., Volkov A.
Perspectives of use outside diabetes, cardiac and nephroprotection
Prikhodko V., Okovity S., Kulikov A.
Patient with hyperuricemia and chronic kidney disease is at the doctor: Peculiarities of curation in accordance with Russian recommendations
Maksudova A., Khalfina T., Almukhametova A.
Indicators of systemic inflammation and state of the cardiovascular system in patients with chronic kidney disease
Zhmurov D., Zhmurov V., Petrov I., Petelina T., Gapon L., Yaroslavskaya E., Petrova Y., Oskolkov S., Zhmurova E., Vanuito E., Ermakova A., Ermakova P.
The importance of choosing a mucoregulator in the treatment of cough in case of upper and lower respiratory tract diseases. Experience of use and perspectives of carbocysteine therapy
Selivanova G., Poteshkina N.
Incidence degree and clinical significance of first detected hypothyroidia in patients with ST-segment elevation myocardial infarction
Gridneva Y., Chesnikova A., Safronenko V., Edlenko E., Zatloukal M.
Value of cardiovascular risk factors in pre-test assessment of coronary heart disease
Roytberg G., Slastnikova I., Sharkhun O., Davydova A.
Life quality in comorbid patients with atrial fibrillation and non-alcoholic fatty liver disease having hyperammoniemia
Alekseenko S., Pan A., Zaikova-Khelimskaya I.
Estimation of the spectrum and severity of COVID-19-associated metabolic changes in patients with non-alcoholic fatty liver disease
Zhuk K., Tarlovskaya E., Vlasova T.
Mineral density bone tissue disorder in case of inflammatory bowel diseases (literature review)
Abdulganieva D., Kupkenova L., Yangurazova A., Myasoutova E.
Blockade of renin-angiotensin-aldosterone system in patients with chronic heart failure and chronic kidney disease
Shutov A., Efremova E., Serov V.
Risk factors, prevalence and rates of chronic kidney disease progression in outpatient patients with arterial hypertension
Sigitova O., Bogdanova A., Saubanova E.
Febuxostat: efficacy and safety of the drug, prospects for application (literature review)
Shchemeleva E., Skorodumova E.
COVID-19 and alcohol liver disease (literature review)
Usanova A., Novikova E., Kuzma F., Sergutova N.
Life, health, “life of disease” and the theory of general pathology
Katz Y., Parkhonyuk E., Skriptsova S.
Meta-analysis of observational cohort studies on the relationships of asymptomatic hyperuricemia with chronic kidney disease
Mazurov V., Drapkina O., Martynov A., Sayganov S., Bashkinov R., Gaydukova I., Sapozhnikov K., Tolkacheva D., Sableva N., Tsinserling A.
COVID-19 pandemic and the state of kidney function
Abyzov A., Kichigin V., Savvateeva O.
Tubulointersticial nephritis
Batyushin M., Zakusilov D., Sigitova O.
Advantages of combined use of sodium-glucose co-transporter type 2 inhibitors and glucagon-like peptide-1 receptor agonists relatively to cardiovascular and renal outcomes in patients with type 2 diabetes mellitus
Salukhov V., Shustov S., Petrankov K.
Mucoactive drugs in the treatment of patients with acute and chronic respiratory pathology
Prozorova G., Budnevsky A., Chernik T.
Gliflozins as remedies for correction of non-alcoholic fatty liver disease neurological complications. Part 2
Prikhodko V., Okovityi S.
Antithrombotic therapy in patients with diabetes mellitus
Rogozhkina E., Ivanova A., Novikov M., Drogashevskaya N., Samatova K., Bogodistaya V.
Female factor in the development of cholelithiasis
Dzhulay G., Dzhulay T.
Difficulties of antianginal therapy selecting in an elderly polymorbid patient with coronary heart disease
Kochetkov A., Telkova S., Dubinina A., Mironova E., Filippova T., Ostroumova O.
Effect of urate-lowering therapy on the progression of chronic kidney disease in patients with osteoarthritis and asymptomatic hyperuricemia
Mazurov V., Sayganov S., Bashkinov R., Sapozhnikov K., Gaydukova I., Tolkacheva D., Sableva N., Inamova O., Petrova M., Tsinserling A.
Chronic kidney disease in primary care practice
Shilov E., Sigitova O.
Correlation between non-alcoholic fatty liver disease and intestinal microbiota dysbiosis
Bystrova A., Khalimov Y., Shodikulova G., Atoev T., Lisker A.
Systematic review of remote monitoring in patients with chronic obstructive pulmonary disease
Senyushkin D., Kupaev V.
Association between diabetes mellitus and lower respiratory tract and pulmonary diseases: scientific discussion
Babak S., Gorbunova M., Gubernatorova E., Malyavin A.
Consensus of experts of the Russian federation gerontologists and geriatricians «Chronic obstructive pulmonary disease in patients of elderly and senile age»
Tkacheva O., Kotovskaya Y., Naumov A., Babak S., Runikhina N., Rozanov A., Babenko I., Khovasova N., Tokareva L.
Diagnostic capabilities of the analysis of exhaled air biochemical composition in respiratory diseases
Teteneva A., Bespalova I., Yarovoy N., Chernov V., Sachkov V., Sorokina T., Nesterovich S., Radionov D., Radionova E.
Clinical and molecular characteristics and peculiarities of nutritional status in non-alcoholic fatty liver disease
Znakharenko E., Gerasimenko O., Maksimov V.
Clinical and prognostic value of the skin autofluorescence parameter in coronary heart disease and peripheral arterial disease patients
Davydova N., Lebedev P., Chernyshev A., Kornilin D., Grishanov V., Komarova M.
Possibilities of early diagnosis of chronic heart failure and chronic kidney disease in patients with type 2 diabetes mellitus at the hospital stage
Demidova T., Izmailova M., Antsiferov M.
Grishmanovskaya O.N. Possibilities for diagnostics of non-alcoholic fatty liver disease in patients with metabolically associated comorbid pathology
Aryamkina O., Dobrynina I., Biek A., Saitov A., Tarasova L., Zapevalov A., Grishmanovsky P., Grishmanovskaya O.
Use of dapagliflozin in a comorbid patient: new opportunities
Panevin T., Eliseev M., Bobkova A., Dimitreva A., Urumova M.
Correlation between estrogen deficiency and non-alcoholic fatty liver disease in female patients
Dora S., Khalimov Y., Mekhtiev S., Lisker A., Zimina M., Semikova G., Volkova A., Cherebillo I., Polyakova Y.
Oxidative stress in chronic obstructive pulmonary disease: Pathogenetic and clinical aspects
Budnevsky A., Avdeev S., Kravchenko A., Vostrikova K.
Additional diagnostic markers of comorbid version of vibration disease combined with arterial hypertension
Gorbunova A., Gerasimenko O., Shpagin I., Belyaeva T., Tolmacheva A., Maksimov V.
Current aspects of the clinical course and outcomes of stable coronary heart disease in patients in the Republic of Dagestan
Mammaev S., Chamsutdinov N., Panahova D., Makhachev O.
Triple fixed combinations therapy in patients with chronic obstructive pulmonary disease
Karoli N., Kanaeva T.
Prognostication of non-alcoholic fatty liver disease in people of young age
Pankova E., Chulkov V., Ektova N.
Therapy of non-alcoholic liver steatosis as an important factor in the prevention of complications of non-alcoholic fatty liver disease
Tarasova L., Tsyganova Y.
The effect of meldonium on the heart rate variability in the complex therapy of patients with chronic heart failure and chronic obstructive pulmonary disease
Statsenko M., Turkina S., Lopushkova Y.
Impact of novel coronavirus infection COVID-19 on the development of acute kidney injury and peculiarities of chronic kidney disease clinical course: Literature review
Bochkareva V., Demko I., Petrova M., Obukhova I., Kozlov E.
Prevalence of chronic kidney disease in the countries worldwide
Bilevich O., Loginova E., Druk I., Chernykh D.
Association of I/D polymorphism of ACE gene with different course of chronic heart failure and myocardial remodeling in patients with coronary heart disease after coronary artery bypass grafting
Magamadov I., Skorodumova E., Kostenko V., Pivovarova L., Ariskina O., Siverina A., Skorodumova E.
Association of fibrosis with nutritional status in case of non-alcoholic fatty liver disease
Znakharenko E., Gerasimenko O., Maksimov V., Gorbunova A.
Still’s disease is a great mimic of systemic inflammatory response syndrome?
Melnikova L., Lokhina T., Berenshtein N., Timofeeva N.
1 - 86 de 86 resultados
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».